Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04725370 · ClinicalTrials.gov registry record

Characterization of Cleft Lip and Palate Conditions in Guatemala

A clinical trial of Cleft Palate and Cleft Lip and Palate, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
629
Enrollment target
1
Study location

NCT04725370: Completed study of Cleft Palate and Cleft Lip and Palate, sponsored by Children's Hospital of Philadelphia.

NCT04725370 is a study of Cleft Palate and Cleft Lip and Palate that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 629 participants, roughly in line with the 604-participant average among 9 other Cleft Palate trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04725370, a study of Cleft Palate and Cleft Lip and Palate, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
629 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare types of and risk factors for cleft lip and palate in a Guatemalan population to a United States population.

Primary Outcome

Presence, laterality, and completeness of cleft lip and/or palate as classified by the LAHSHAL system, data gathered by physical exam

Interventions

  • OTHER NA - survey instrument

Study Locations (1)

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 629 participants
Start Date 2017-10-30
Est. Completion 2020-03-13
Children's Hospital of Philadelphia

431 total trials

What the finished NCT04725370 record still lists

NCT04725370 is an observational study that tracks outcomes without assigning an intervention. The registered 629 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 604-participant average among 9 other Cleft Palate trials with a reported enrollment target.

The record links to 3 conditions, with Cleft Palate appearing as the primary indexed condition, and to 1 intervention - of which NA - survey instrument is the first listed.

NCT04725370 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04725370 about?

NCT04725370 is a clinical study titled "Characterization of Cleft Lip and Palate Conditions in Guatemala". The purpose of this study is to compare types of and risk factors for cleft lip and palate in a Guatemalan population to a United States population.

What is the current status of trial NCT04725370?

This trial is currently completed. The enrollment target is 629 participants. The study started on 2017-10-30. Estimated completion is 2020-03-13.

What conditions does trial NCT04725370 study?

This clinical trial studies the following conditions: Cleft Palate, Cleft Lip and Palate, Cleft Lip.

What interventions are being tested in trial NCT04725370?

The interventions under investigation include: NA - survey instrument (OTHER).

Who is sponsoring clinical trial NCT04725370?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04725370 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cleft Palate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04725370's enrollment target sits among peer trials

629 2nd of 9 the highest of 9 other Cleft Palate trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cleft Palate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04704921 · 630 participants · Phase 2

    Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

  • NCT04707729 · 630 participants · NA

    ROX Index for the Timing of Intubation in Nasal High Flow

  • NCT05061550 · 630 participants · Phase 2

    Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • NCT05224440 · 630 participants · NA

    National Sponsorship Program for Transitioning Service Members

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04725370, the US trial registry maintained by the National Library of Medicine. NCT04725370 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.